Kinase Inhibitors Offer New Hope for Mantle Cell Lymphoma

patientpower has 2398 videos Subscribe Here

Description: Dr. Peter Martin, from Weill Cornell Medical College, explains a new class of drugs that is expanding the treatment landscape for mantle cell lymphoma, a challenging disease for which the current approaches have been ineffective or carried high risk. Called tyrosine kinase inhibitors (TKIs), these drugs have shown promising results for MCL patients in an ongoing phase II clinical trial. Dr. Martin explains the drug and the trials, and assures patients that this is just the "tip of the iceberg."
Shared By : patientpower
Posted on : 03/20/12
Added : 6 years ago
Category : Lymphoma